Streetbeat News

Products Services

ICPT

Intercept Pharmaceuticals announced initial results from a planned interim analysis of its ongoing Phase 2 study 747-213, showing the therapeutic potential of the combination of obeticholic acid (OCA) and bezafibrate in primary biliary cholangitis (PBC). Over half of the patients receiving OCA5-10/B400 achieved normal range alkaline phosphatase (ALP) at four weeks with continued improvement through week 12. ICPT shares are up 6.81% at $12.08.

Portfolio Pulse from Vandana Singh

June 07, 2023 | 6:20 pm

CARR

Carrier Global shares are trading higher due to potential increased demand for air purifiers as a result of air pollution caused by Canadian wildfires.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 6:18 pm

AAPL

WBD

CNN's attempt to rebrand itself as a Gen Z-focused news outlet, dubbed 'Zazification,' has failed to gain traction, leading to speculation that the network may be sold.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 6:17 pm

DPRO

Traders are circulating Draganfly as a potential fire-fighting trade due to its public safety solutions. The company's technology can be used for fire prevention and response.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 6:04 pm

COYA

Coya Therapeutics reported additional biomarker and brain imaging results from an open-label proof-of-concept study for COYA 301, its Alzheimer's Disease candidate. The study showed a statistically significant improvement in cognitive function and a reduction of blood biomarkers and proinflammatory cytokines. COYA shares are up 4.61% at $4.54.

Portfolio Pulse from Vandana Singh

June 07, 2023 | 6:00 pm

CSCO

T

Cisco Systems has partnered with AT&T to enhance connectivity and advance the calling landscape for hybrid workforces. The collaboration will offer SD-WAN connectivity with add-on services such as 5G and broadband for businesses. Webex Calling will be integrated with the AT&T mobile network, and AT&T Cloud Voice with Webex Go will be available for all Webex Calling users in the U.S. later this year.

Portfolio Pulse from Lekha Gupta

June 07, 2023 | 5:45 pm

HSTO

Histogen has been granted European Patent Number EP3814327 for its pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases.

Portfolio Pulse from Happy Mohamed

June 07, 2023 | 5:38 pm

BXRX

Baudax Bio announced additional positive results from its Phase 2 trial of BX1000 for neuromuscular blockade in surgery patients. The highest dose of BX1000 showed comparable results to rocuronium, with more predictable recovery margins.

Portfolio Pulse from Vandana Singh

June 07, 2023 | 5:23 pm

VTGN

Vistagen Therapeutics announced that its investigational neuroactive nasal spray, PH80, demonstrated statistically significant efficacy in treating menopausal hot flashes in a Phase 2A study. PH80 was well-tolerated with no serious adverse events, and showed a significant reduction in the daily number of hot flashes compared to the placebo.

Portfolio Pulse from Vandana Singh

June 07, 2023 | 5:15 pm

STM

STMicroelectronics announced a joint venture with Sanan Optoelectronics to manufacture 200mm semiconductors in China. The facility is expected to begin production in Q4 2025 and support the increasing demand for electric vehicles, industrial, and energy applications in China. The total cost for the full buildout is estimated to be $3.2 billion.

Portfolio Pulse from Erica Kollmann

June 07, 2023 | 4:45 pm